ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 68 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 38.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,000 | -18.2% | 48,944 | 0.0% | 0.00% | – |
| Q1 2017 | $22,000 | -8.3% | 48,944 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -4.0% | 48,944 | 0.0% | 0.00% | – |
| Q3 2016 | $25,000 | -49.0% | 48,944 | 0.0% | 0.00% | – |
| Q2 2016 | $49,000 | +48.5% | 48,944 | 0.0% | 0.00% | – |
| Q1 2016 | $33,000 | -44.1% | 48,944 | 0.0% | 0.00% | – |
| Q4 2015 | $59,000 | -45.9% | 48,944 | 0.0% | 0.00% | – |
| Q3 2015 | $109,000 | -4.4% | 48,944 | 0.0% | 0.00% | – |
| Q2 2015 | $114,000 | +11.8% | 48,944 | 0.0% | 0.00% | – |
| Q1 2015 | $102,000 | 0.0% | 48,944 | 0.0% | 0.00% | – |
| Q4 2014 | $102,000 | -22.1% | 48,944 | 0.0% | 0.00% | – |
| Q3 2014 | $131,000 | -28.4% | 48,944 | 0.0% | 0.00% | – |
| Q2 2014 | $183,000 | -56.8% | 48,944 | +17.2% | 0.00% | -100.0% |
| Q1 2014 | $424,000 | +20.5% | 41,744 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $352,000 | -10.4% | 41,744 | -1.6% | 0.00% | 0.0% |
| Q3 2013 | $393,000 | -5.5% | 42,444 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $416,000 | – | 42,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|